Drugs that contain Azacitidine
1. Onureg patents expiration
ONUREG's oppositions filed in EPO
ONUREG Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11571436 | BRISTOL | Oral formulations of cytidine analogs and methods of use thereof |
May, 2029
(5 years from now) | |
| US8846628 | BRISTOL | Oral formulations of cytidine analogs and methods of use thereof |
Jun, 2030
(6 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-320) | Sep 01, 2027 |
| New Product(NP) | Sep 01, 2023 |
Market Authorisation Date: 01 September, 2020
Treatment: Continued treatment of adults with acute myeloid leukemia who achieved first complete remission (cr) or cr with incomplete blood count recovery following intensive induction chemotherapy and are not a...
Dosage: TABLET;ORAL
How can I launch a generic of ONUREG before it's drug patent expiration?
More Information on Dosage
ONUREG family patents
